Generic VEL/SOF With or Without RBV for HIV/HCV Coinfected Patients

NCT03250910 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

228

Enrollment

OTHER

Sponsor class

Conditions

Hepatitis C Virus Infection, Response to Therapy of
Human Immunodeficiency Virus

Interventions

DRUG: Sofosbuvir and Velpatasvir
DRUG: Ribavirin

Sponsor

National Taiwan University Hospital